Key Statistics
Market Cap$4.75B
P/E RatioN/A
Div. Yield—
EPS (TTM)-$6.47
52W High$78.48
52W Low$30.04
SectorHEALTHCARE
IndustryBIOTECHNOLOGY
Employees393
Price Performance
1 Week+8.22%
3 Month-10.23%
1 Year+51.59%
FinancialsAnnual · QuiverQuant
Revenue$371.21M
Assets$2.23B
Liabilities$346.77M
Net Income$153.61M loss
About
CRISPR Therapeutics AG, a gene editing company, focuses on the development of gene-based transformative drugs for serious human diseases. The company is headquartered in Zug, Switzerland.
WebullFree stocks
Advanced charting, extended hours trading, and free stock for new accounts.
Analyze CRSP with professional charts— Free to start
Price data sourced from Polygon.io (previous trading day close). Fundamentals from Alpha Vantage. Insider trades from SEC EDGAR. Cached via Cloudflare KV.